Lucid Diagnostics EBITDA Growth & History (LUCD)

Lucid Diagnostics's calculated EBITDA was −$48.8M for fiscal 2025.

View full Lucid Diagnostics company overview

Lucid Diagnostics annual ebitda history

Lucid Diagnostics annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20252025-12-31−$48.8M−$3.9M
20242024-12-31−$44.9M$1.1M
20232023-12-31−$46.0M$8.3M
20222022-12-31−$54.3M−$26.9M
20212021-12-31−$27.4M

Lucid Diagnostics ebitda trends

Across the available reported history, Lucid Diagnostics's ebitda decreased from −$44.9M to −$48.8M, a change of −$3.9M. The latest reported quarter, Q2 2026, shows −$12.6M.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Lucid Diagnostics filings at SEC.gov ↗